Challenges with risk mitigation in academic drug discovery: finding the best solution

Click to increase image sizeClick to decrease image size

Declaration of interest

A Roy has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

A Roy is supported by a Cancer Center support grant from the National Cancer Institute [P3OCA 168524] and a National Institute of General Medical Sciences (NIGMS) Chemical Biology of Infectious Disease grant [P20GM 113117].